Sanjay Kumar Nayak

Sanjay Kumar Nayak

Director Director DIN 06466666
DIN 06466666 First appointment Oct 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2013
Shareholding value •••• Premium profile

About Sanjay Kumar Nayak

Data last updated:

Sanjay Kumar Nayak was a Director at Evertogen Life Sciences Limited (2015–2021) and Director at Organosyn Life Sciences Private Limited (2013–2021). The companies operate in Pharma.

DIN 06466666
Primary Designation Director
Industry Pharma
First Appointment 01 Oct 2013

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Evertogen Life Sciences Limited U24232TG2013PLC085349
Director13 Feb 20152013₹89.28 Cr (FY 2024)Active
Director01 Oct 20132011₹40.64 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Evertogen Life Sciences Limited
Organosyn Life Sciences Private Limited
Premium access

Shareholding and investment profile for Sanjay Kumar Nayak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Kumar Nayak

Sanjay Kumar Nayak was first appointed on 01 Oct 2013 as Director at Organosyn Life Sciences Private Limited. The most recent appointment on record is 13 Feb 2015 at Evertogen Life Sciences Limited.

Sanjay Kumar Nayak held 2 earlier board appointments: Evertogen Life Sciences Limited (Director, 13 Feb 2015 to 25 May 2021); Organosyn Life Sciences Private Limited (Director, 01 Oct 2013 to 25 May 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available